about
Immuron Ltd is a commercial and clinical-stage biopharmaceutical company with a proprietary technology platform focused on polyclonal antibodies that can address unmet medical needs. The company's commercial products are: Travelan (an orally administ...
Read More
1.16
-0.03
(-2.52%)
43,882
XNAS Volume
XNAS 25 Sep, 2026 5:30 PM (EDT)
Board Meeting
The latest board meeting for Immuron Ltd (ADR) took place on 25 Sep 2026, for the purpose of Immuron Ltd Annual Report for 2026
See details
Not Eligible
Expensive Valuation
Technically Neutral
Immuron Ltd (ADR) Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..